(S (NP-SBJ (JJ Interstitial) (NN deletion)) (VP (VBZ constitutes) (NP (NP (DT the) (JJ major) (NN mechanism)) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (NP (NN heterozygosity)) (PP (IN on) (NP (NN chromosome) (NN 20q))))) (PP (IN in) (NP (NN polycythemia) (NN vera))))))) (. .))
(S (NP-SBJ (NP (DT An) (VBN acquired) (NN deletion)) (PP (IN of) (NP (NP (DT the) (JJ long) (NN arm)) (PP (IN of) (NP (NN chromosome) (CD 20)))))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ recurrent) (NN abnormality)) (PP (IN in) (NP (NP (JJ myeloproliferative) (NNS disorders)) (, ,) (NP (RB particularly) (NP (UCP-COOD (NP (NN polycythemia) (NN vera)) (CC and) (ADJP (JJ myelodysplastic))) (NNS syndromes))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN association)) (PP (IN of) (NP (NN 20q) (NNS deletions))) (PP (IN with) (NP (JJ myeloid) (`` ") (NN stem) (NN cell) ('' ") (NNS disorders)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (DT the) (NNS deletions)) (VP (VBP mark) (NP (NP (DT the) (NN site)) (PP (IN of) (NP (QP (CD one) (CC or) (JJR more)) (NNS genes))) (, ,) (SBAR (WHNP-5 (NP-COOD (NP (NN loss)) (CC or) (NP (NN inactivation))) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ (-NONE- *T*-5)) (VP (VBZ plays) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (JJ normal) (JJ hematopoietic) (NNS progenitors))))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (ADVP-TMP (RB recently)) (VP-COOD (VP (VBN performed) (NP (NP (DT a) (JJ detailed) (JJ molecular) (NN analysis)) (PP (IN of) (NP (NP (JJ 20q) (NNS deletions)) (PP (IN in) (NP (NP (NP (JJ peripheral) (NN blood)) (PRN (-LRB- -LRB-) (NP (NN PB)) (-RRB- -RRB-))) (NNS granulocytes))))))) (CC and) (VP (VBN defined) (NP (NP (DT a) (ADJP (RB commonly) (VBN deleted)) (NN region)) (PP (IN of) (NP (QP (CD 16) (TO to) (CD 21)) (NP (NP (NN centimorgan)) (PRN (-LRB- -LRB-) (NP (NN cM)) (-RRB- -RRB-))))))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP (TO To) (ADVP (RBR further)) (VP (VB reduce) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (DT the) (JJ common) (VBN deleted) (NN region))))))) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN searched) (PP (IN for) (NP (NP-COOD (NP (JJ small) (NNS deletions)) (CC or) (NP (JJ mitotic) (NN recombination) (NNS events))) (, ,) (SBAR (WHNP-6 (NP (DT neither)) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ-7 (-NONE- *T*-6)) (VP (MD would) (VP (VB be) (VP (VBN detected) (NP (-NONE- *-7)) (PP (IN by) (NP (JJ conventional) (NNS cytogenetics)))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN studied) (NP-COOD (NP (NP (CD 48) (NNS patients)) (PP (IN with) (NP (NN polycythemia) (NN vera)))) (CC and) (NP (NP (CD four) (NNS patients)) (PP (IN with) (NP (JJ idiopathic) (NN myelofibrosis))))))) (. .))
(S (PP (IN In) (NP (DT each) (NN case))) (, ,) (NP-SBJ (JJ cytogenetic) (NN analysis)) (VP-COOD (VP (VBD had) (RB either) (VP (VBN failed))) (CC or) (VP (VBD had) (VP (VBN shown) (NP (NP (DT no) (NNS abnormalities)) (PP (IN of) (NP (NN chromosome) (CD 20))))))) (. .))
(S (NP-SBJ-8 (NP (CD Seventeen) (NN microsatellite) (NNS markers)) (SBAR (WHNP-9 (WDT that)) (S (NP-SBJ (-NONE- *T*-9)) (VP (VBP span) (NP (DT the) (JJ common) (VBN deleted) (NN region)))))) (VP (VBD were) (VP (VBN used) (NP (-NONE- *-8)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB search) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (NN heterozygosity))) (PP (IN in) (NP (NN granulocyte) (NN DNA)))))))))) (. .))
(S (NP-SBJ-10 (NP (DT No) (NN instance)) (PP (IN of) (NP (NN microsatellite) (NN instability)))) (VP (VBD was) (VP (VBN observed) (NP (-NONE- *-10)) (PP (IN in) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 880) (NNS comparisons)) (PP (IN of) (NP (NP-COOD (NP (NN granulocyte)) (CC and) (NP (NN T-cell))) (NN DNA))))))))) (. .))
(S (NP-SBJ (NP (NN Granulocyte) (NN DNA)) (PP (IN from) (NP (CD four) (NNS patients)))) (VP (VBD exhibited) (NP (NP (NN allele) (NN loss)) (PP (IN on) (NP (NN 20q))))) (. .))
(S (PP (IN In) (NP (DT each) (NN case))) (NP-SBJ-11 (DT the) (NN allele) (NN loss)) (VP (VBD was) (VP (VBN caused) (NP (-NONE- *-11)) (PP (IN by) (NP-LGS (DT an) (JJ interstitial) (NN deletion))) (SBAR-COOD (SBAR (IN because) (S (NP-SBJ-12 (NP (NN heterozygosity)) (PP (IN at) (NP (JJ distal) (NNS markers)))) (VP (VBD was) (VP (VBN retained) (NP (-NONE- *-12)))))) (CC and) (SBAR (IN because) (S (NP-SBJ (JJ quantitative) (NN Southern) (NN blotting)) (VP (VBD demonstrated) (NP (NN hemizygosity)))))))) (. .))
(S (NP-SBJ-13 (NP (NN Loss)) (PP (IN of) (NP (NN heterozygosity))) (PP (IN in) (NP (NN PB) (NNS granulocytes)))) (VP (MD would) (VP (VB be) (VP (VBN masked) (NP (-NONE- *-13)) (PP (IN by) (NP-LGS (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ significant) (NNS numbers)) (PP (IN of) (NP (NP (JJ normal) (NNS granulocytes)) (VP (RB not) (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (DT the) (JJ malignant) (NN clone))))))))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP-SBJ-14 (NP (DT the) (JJ human) (NN androgen) (NN receptor) (NN assay)) (PRN (-LRB- -LRB-) (NP (NN HUMARA)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (NP-15 (-NONE- *-14)) (S (NP-SBJ (-NONE- *-15)) (VP (TO to) (VP (VB determine) (NP (NN granulocyte) (NN clonality))))))) (. .))
(S (PP (IN In) (NP (QP (CD 21) (IN of) (CD 27)) (JJ informative) (NN female) (NNS patients))) (NP-SBJ (NP (DT the) (NN majority)) (PP (IN of) (NP (DT the) (NNS granulocytes)))) (VP (VBD were) (ADJP-PRD (RB clonally) (VBN derived))) (. .))
(S-COOD (S (PP (IN In) (NP (CD 5) (NNS patients))) (NP-SBJ (DT the) (NNS granulocytes)) (VP (VBD appeared) (ADJP-PRD (JJ polyclonal)))) (CC and) (S (PP (IN in) (NP (CD 1) (NN patient))) (NP-SBJ-17 (JJ unilateral) (NN X) (NN inactivation)) (VP (VBD was) (VP (VBN observed) (NP (-NONE- *-17)) (PP (IN in) (NP-COOD (CC both) (NP (NNS granulocytes)) (CC and) (NP (JJ T) (NNS cells))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP show) (SBAR (IN that) (, ,) (S (PP (IN in) (NP (NP (DT the) (JJ vast) (NN majority)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN presented) (NP (-NONE- *)) (ADVP (RB here))))))) (, ,) (NP-SBJ-16 (DT the) (NN failure) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB detect) (NP (NP (NN loss)) (PP (IN of) (NP (NN heterozygosity)))))))) (VP (MD can) (RB not) (VP (VB be) (VP (VBN attributed) (NP (-NONE- *-16)) (PP (TO to) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ normal) (JJ polyclonal) (NNS granulocytes))))))))))) (. .))
(S (NP-SBJ (PRP$ Our) (NNS results)) (ADVP (RB therefore)) (VP (VBP show) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (NP (NN allele) (NN loss)) (PP (IN on) (NP (NN chromosome) (NN 20q))) (PP (IN in) (NP (NN polycythemia) (NN vera)))) (VP (VBZ does) (RB not) (ADVP (RB commonly)) (VP (VB involve) (NP-COOD (NP (JJ mitotic) (NN recombination)) (CC or) (NP (NN chromosome) (NN loss))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NN microsatellite) (NN instability)) (VP (VBZ is) (NP-PRD (DT a) (JJ rare) (NN event)) (PP (IN in) (NP (DT this) (NN disorder)))))))) (. .))
